Lv1
50 积分 2025-04-01 加入
The evolving landscape of RAS-targeted therapies
2个月前
已完结
Abstract 6737: RAS inhibitors as payloads of ADCs to treat RAS-mutant tumors
2个月前
已关闭
The evolving landscape of RAS-targeted therapies
3个月前
已完结
Precision Chemoradiotherapy via EGFR Targeting with Radiotherapy-Activated Drug Conjugates
4个月前
已完结
Diligent Design Enables Antibody-ASO Conjugates with Optimal Pharmacokinetic Properties
6个月前
已完结
Antibody-exatecan conjugates with a novel self-immolative moiety overcome resistance in colon and lung cancer
8个月前
已完结
皖公网安备34019202002308
